亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

云南思摩貝特生物科技有限公司  

有機化學原料的研發(fā),生產(chǎn),銷售

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:馮雪蘭
  • 電話:0871-68352571
  • 郵件:2318848591@qq.com
  • 傳真:0871-68319152
  • QQ:2318848591
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 供應(yīng)大量地西他濱
供應(yīng)大量地西他濱
單價 面議對比
詢價 暫無
發(fā)貨 云南昆明市付款后3天內(nèi)
型號 2353-33-5
過期 長期有效
更新 2013-09-16 16:01
 
詳細信息

  產(chǎn)品中文名稱: 地西他濱
產(chǎn)品中文別名: 5-氮雜-2-脫氧胞苷
產(chǎn)品英文名稱: Decitabine
產(chǎn)品英文別名: 4-amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-1,3,5-Triazin-2(1H)-one; 4-amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-s-Triazin-2(1H)-one; 2'-Deoxy-5-azacytidine; 2-Desoxy-5-azacytidine; 5-Aza-2'-deoxycytidine; 5-Azadeoxycytidine; DAC; Dacogen; NSC 127716
 
 
  CAS 號: 2353-33-5
分子式: C8H12N4O4
分子量: 228.21
 
©2025 云南思摩貝特生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:13016  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |